Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thymoma 2Primary Inoperable Thymoma 1Pleural Effusion 1Neoplasms 1Lymphangiomyoma 1Lymphangioleiomyomatosis 1Disease 1Chylous Ascites 1Chylothorax 1Ascites 1

Interventions

Tomography, X-Ray Computed 2Hematologic Tests 2Blood Specimen Collection 2tivozanib 1pembrolizumab 1aflibercept 1Videotape Recording 1Urination 1Thoracoscopy 1Thoracic Surgical Procedures 1Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Referral and Consultation 1Octreotide 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Ipilimumab 1Interviews as Topic 1Interleukin-15 1In Situ Hybridization 1Immunohistochemistry 1Exercise 1Erlotinib Hydrochloride 1Equipment and Supplies 1Educational Status 1Dipeptidyl-Peptidase IV Inhibitors 1Diagnostic Tests, Routine 1Diagnosis 1Clinical Laboratory Techniques 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Octreotide × Thoracic × Clear all
NCT00332969 2017-03-31

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Novartis

Phase 2 Completed
25 enrolled
Thoracic

Disease, Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡